Breath Testing Segment to Drive SIBO Diagnostics Market During 2021–2028
According to The Insight Partners market research study titled “Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Diagnosis and Type,” the market is expected to reach US$ 194,604.51 thousand by 2028 from US$ 138,324.23 thousand in 2020. It is estimated to grow at a CAGR of 4.4% from 2021 to 2028. The report highlights the trends prevalent in the market and the factors driving the market along with those that act as deterrents to its growth.
Based on diagnosis, the SIBO diagnostics market is segmented into breath testing, small intestine aspirate and fluid culture test, blood test, and others. In 2020, the breath testing segment held the largest share of the market, and is also expected to grow at the fastest rate during the coming years. The growth of the market is attributed to its advantages, such as non-invasive, patient-friendly, simplicity, and low-cost.
The global SIBO diagnostics market is driven by increasing incidence of IBS and SIBO and advantages offered by breath tests. However, limitation of diagnostics is a key factor restraining the market growth.
Prominent players operating in SIBO diagnostics market include Genova Diagnostics; SIBO Diagnostics; Commonwealth Diagnostics International; Aerodiagnostics, LLC; SIBOTest; Metabolic Solutions, Inc.; Pivotal Diagnostics; DirectLabs, LLC; Vibrant Wellness; and Health Associates Medical Group. The companies have maximized their growth with several organic strategies to enhance the market value and maintain position in the market. For instance, in February 2020, Commonwealth Diagnostics International (CDI), Inc., announced the commercial re-launch of IBSchek, the first clinically validated biomarker blood test for diarrhea-predominant and mixed-type Irritable Bowel Syndrome (IBS-D, IBS-M) in a new at-home capillary collection kit.
Global SIBO Diagnostics Market, by Region, 2020 (%)
The report segments the global SIBO diagnostics market as follows:
By Diagnosis
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
According to The Insight Partners market research study titled “Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Diagnosis and Type,” the market is expected to reach US$ 194,604.51 thousand by 2028 from US$ 138,324.23 thousand in 2020. It is estimated to grow at a CAGR of 4.4% from 2021 to 2028. The report highlights the trends prevalent in the market and the factors driving the market along with those that act as deterrents to its growth.
Based on diagnosis, the SIBO diagnostics market is segmented into breath testing, small intestine aspirate and fluid culture test, blood test, and others. In 2020, the breath testing segment held the largest share of the market, and is also expected to grow at the fastest rate during the coming years. The growth of the market is attributed to its advantages, such as non-invasive, patient-friendly, simplicity, and low-cost.
The global SIBO diagnostics market is driven by increasing incidence of IBS and SIBO and advantages offered by breath tests. However, limitation of diagnostics is a key factor restraining the market growth.
Prominent players operating in SIBO diagnostics market include Genova Diagnostics; SIBO Diagnostics; Commonwealth Diagnostics International; Aerodiagnostics, LLC; SIBOTest; Metabolic Solutions, Inc.; Pivotal Diagnostics; DirectLabs, LLC; Vibrant Wellness; and Health Associates Medical Group. The companies have maximized their growth with several organic strategies to enhance the market value and maintain position in the market. For instance, in February 2020, Commonwealth Diagnostics International (CDI), Inc., announced the commercial re-launch of IBSchek, the first clinically validated biomarker blood test for diarrhea-predominant and mixed-type Irritable Bowel Syndrome (IBS-D, IBS-M) in a new at-home capillary collection kit.
Global SIBO Diagnostics Market, by Region, 2020 (%)
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market to Grow at a CAGR of 4.4% to reach US$ 194,604.51 thousand from 2020 to 2028
Download Free SampleSmall Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnosis (Breath Testing, Small Intestine Aspirate and Fluid Culture Test, Blood Test, and Others); Type (Hydrogen-predominant SIBO, Methane-predominant SIBO, and Recurrent SIBO), and Geography
By Diagnosis
- Breath Testing
- 14C Xylose Breath Test
- Hydrogen Breath Tests
- 14C Glycocholic Acid Breath Test
- Malabsorption Tests
- Small Intestine Aspirate and Fluid Culture Test
- Blood Test
- Others
- Hydrogen-predominant SIBO
- Methane-predominant SIBO
- Recurrent SIBO
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- Japan
- China
- India
- Australia
- South Korea
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Download Free PDF Brochure